L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension

• Status: Recruiting
• Trial end date: 2023-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study compares L-arginine Versus Sildenafil as treatment for pulmonary hypertension in Children with Beta Thalassemia

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sherief Abd-Elsalam
• Treatments: Sildenafil Citrate

Criteria

Inclusion Criteria:

• Children with thalassemia and pulmonary hypertension.

Exclusion Criteria:

• Rheumatic heart diseases.

• Other comorbid disease